MIR6862-1

Q-omics provides the consensus-scored MIR6862-1 profile across patient tissues and cancer cell-line models. MIR6862-1 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MIR6862-1 RNA expression shows 358 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where MIR6862-1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes MIR6862-1 survival associations across molecular data types. MIR6862-1 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR6862-1 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	STAD (81)	view →

This table ranks reproducible MIR6862-1 RNA expression–survival associations across cancer types. High MIR6862-1 expression shows unfavorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for MIR6862-1 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.234	0.691	<.001	81	view →

Pink = unfavorable, green = favorable. all 1 lineages →

MIR6862-1-STAD (OS)

Explore this curve interactively →